Genovis Investor Relations » Press Releases

April 23, 2026 08:00 (CEST) Genovis AB publishes Annual Report 2025 Regulatory

April 15, 2026 12:15 (CEST) NOTICE OF ANNUAL GENERAL MEETING OF GENOVIS AB (PUBL) Regulatory

March 31, 2026 09:00 (CEST) Genovis and Plasmidsaurus Introduce SEQguard™ Dino Preserve — Enabling Ambient-Temperature RNA Shipping for Next-Generation Sequencing

March 25, 2026 08:30 (CET) Genovis Enters Non-Exclusive License Agreement for EndoS2 Enzyme Technology for Antibody-Drug Conjugate (ADC) Development and Commercialization Regulatory MAR

March 19, 2026 08:30 (CET) Genovis and Single Cell Discoveries Enter Strategic Partnership for Large-Scale Transcriptomics Analyses

February 12, 2026 08:00 (CET) Genovis AB Year-end Report January-December 2025 Regulatory MAR

November 07, 2025 08:00 (CET) Genovis AB Interim report January-September 2025 Regulatory MAR

October 17, 2025 08:30 (CEST) Genovis receives order worth approximately 1 million euros from global pharmaceutical company Regulatory MAR

August 12, 2025 08:00 (CEST) Genovis AB Half-Yearly report January – June 2025 Regulatory MAR

July 24, 2025 08:30 (CEST) Genovis Expands License Agreement to Access Proprietary Enzyme Technology for Therapeutic Antibody-Drug Conjugate Development

Press Releases